Clinical value and cost saving of therapeutic drug monitoring of infliximab in adult patients with inflammatory bowel disease. – OSLM

Publication

Clinical value and cost saving of therapeutic drug monitoring of infliximab in adult patients with inflammatory bowel disease.

Journal : Clinical medicine (London, England)

March 1, 2020

Authors : Ganesananthan S, Durai D

b

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics Observational

10.7861/clinmed.20-2-s23 : DOI

32409349 : PMID

PMC7243528 : PMC-ID